Showing results (51-60 of 163) with videos related to
Sort By:
Pageof 17
Journal of Enzyme Inhibition and Medicinal Chemistry|December 13, 2021
Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studiesMohamed M Khalifa, Ahmed A Al-Karmalawy, Eslam B Elkaeed, et al.Frontiers in Chemistry|October 11, 2021
Design and Synthesis of New Quinoxaline Derivatives as Potential Histone Deacetylase Inhibitors Targeting Hepatocellular Carcinoma: In Silico, In Vitro, and SAR StudiesChao Ma, Mohammed S Taghour, Amany Belal, et al.Frontiers in Chemistry|May 21, 2021
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 ReceptorAhmed A Al-Karmalawy, Mohammed A Dahab, Ahmed M Metwaly, et al.Molecules (Basel, Switzerland)|September 23, 2022
New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer StudiesEslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.Antiviral Therapy|September 5, 2023
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approachEslam B Elkaeed, Bshra A Alsfouk, Tuqa H Ibrahim, et al.Bioorganic Chemistry|July 13, 2020
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzymeKhaled El-Adl, Abdel-Ghany A El-Helby, Helmy Sakr, et al.Saudi Journal of Biological Sciences|September 30, 2021
Traditional ancient Egyptian medicine: A reviewAhmed M Metwaly, Mohammed M Ghoneim, Ibrahim H Eissa, et al.Plants (Basel, Switzerland)|July 9, 2022
Combined In Silico and Experimental Investigations of Resveratrol Encapsulation by Beta-CyclodextrinAinara Iskineyeva, Serik Fazylov, Ryszhan Bakirova, et al.RSC Advances|April 6, 2023
Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agentsAnas Ramadan Kotb, Abdallah E Abdallah, Hazem Elkady, et al.Chemistry & Biodiversity|November 14, 2024
Discovery of New Immunomodulatory Anticancer Thalidomide Analogs: Design, Synthesis, Biological Evaluation and In Silico StudiesAbdallah E Abdallah, Ibrahim H Eissa, Ahmed B M Mehany, et al.Pageof 17